CNSY
Cerenome, Inc. - Common Stock (CNSY)
$08
About Cerenome, Inc. - Common Stock (CNSY)
Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Details
Daily high
$3.20
Daily low
$3.07
Price at open
$3.20
52 Week High
$23.42
52 Week Low
$2.90
Market cap
22.0M
Dividend yield
-
Volume
92,587
Avg. volume
84,628
P/E ratio
-.73
Cerenome, Inc. - Common Stock News
Details
Daily high
$3.20
Daily low
$3.07
Price at open
$3.20
52 Week High
$23.42
52 Week Low
$2.90
Market cap
22.0M
Dividend yield
-
Volume
92,587
Avg. volume
84,628
P/E ratio
-.73